Masimo CORP (MASI) — 8-K Filings

8-K Filings (32)

• 8-K Filing — Dec 3, 2025
• Masimo Corp. Enters New Agreements, Terminates Others — Dec 1, 2025 Risk: medium
  On December 1, 2025, Masimo Corp. entered into a material definitive agreement and simultaneously terminated another. The company also created a direct financia
• Masimo Corp. Files 8-K Amendment — Sep 29, 2025 Risk: low
  Masimo Corp. filed an 8-K/A amendment on September 29, 2025, related to events on September 23, 2025. The filing is an amendment to a previous 8-K report and co
• Masimo Corp Files 8-K on Asset Acquisition/Disposition — Sep 23, 2025 Risk: medium
  On September 23, 2025, Masimo Corporation filed an 8-K report detailing the completion of an acquisition or disposition of assets. The filing also includes Regu
• Masimo Corp. Announces Executive and Board Changes — Aug 19, 2025 Risk: medium
  Masimo Corp. announced on August 18, 2025, changes in its executive team and board of directors. The filing details the departure of certain officers and the el
• Masimo Corp. Appoints Interim CFO, Elects New Directors — Jun 12, 2025 Risk: medium
  Masimo Corp. announced on June 6, 2025, the departure of its Chief Financial Officer, Micah R. Estlick, effective June 7, 2025. The company also appointed Arthu
• Masimo Corp Files 8-K with Regulatory Updates — May 27, 2025 Risk: low
  Masimo Corporation filed an 8-K on May 27, 2025, reporting on various events including a Regulation FD Disclosure, other events, and financial statements. The f
• Masimo Corp Files 8-K Report — May 6, 2025 Risk: low
  On May 6, 2025, Masimo Corporation filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific transactions, financi
• Masimo Corp. Files 8-K on Shareholder Votes — Apr 30, 2025 Risk: low
  Masimo Corp. filed an 8-K on April 30, 2025, reporting on matters submitted to a vote of its security holders as of April 29, 2025. The filing details the compa
• Masimo Corp. Files 8-K with Corporate Updates — Feb 19, 2025 Risk: medium
  Masimo Corp. filed an 8-K on February 19, 2025, reporting events that occurred on February 12, 2025. The filing indicates potential amendments to articles of in
• Masimo Corp. Announces Director Changes and Officer Compensation — Feb 7, 2025 Risk: low
  Masimo Corp. announced on February 6, 2025, the departure of director David Bruce and the election of new director Michael J. Farrell. The company also reported
• Masimo Corp. Reports Board Changes and Executive Compensation Updates — Jan 31, 2025 Risk: medium
  Masimo Corp. announced on January 30, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the de
• Masimo Corp CFO Departs; Settlement Reached — Jan 21, 2025 Risk: medium
  Masimo Corp. announced on January 17, 2025, the departure of its Chief Financial Officer, Arthur Dimling, effective immediately. The company has appointed Brad
• Masimo Corp Files 8-K on Financials — Jan 16, 2025 Risk: low
  Masimo Corporation filed an 8-K on January 16, 2025, reporting on its results of operations and financial condition. The filing also included Regulation FD disc
• Masimo Corp. Reports Director Departure, New CMO — Nov 18, 2024 Risk: medium
  Masimo Corp. announced on November 13, 2024, the departure of Director David Bruce and the appointment of Dr. Michael O'Reilly as Chief Medical Officer. The com
• Masimo Corp Files 8-K on Financials — Nov 5, 2024 Risk: low
  Masimo Corporation filed an 8-K on November 5, 2024, to report on its results of operations and financial condition. The filing also includes Regulation FD disc
• Masimo Corp Files 8-K: Operations, Personnel Changes, Financials — Oct 29, 2024 Risk: medium
  Masimo Corporation filed an 8-K on October 24, 2024, reporting on its results of operations and financial condition. The filing also disclosed the departure of
• Masimo Corp. Announces Board Changes and Officer Compensation — Oct 18, 2024 Risk: medium
  Masimo Corp. announced on October 16, 2024, the departure of director Robert E. Yauch and the election of new directors, including Dr. David E. Pearse and Mr. S
• Masimo Corp Files 8-K on Operations, Directors, and Votes — Sep 25, 2024 Risk: medium
  Masimo Corporation filed an 8-K on September 25, 2024, reporting on results of operations, director departures, and matters submitted to a vote. The filing also
• Masimo Corp Files 8-K: Regulation FD Disclosure & Exhibits — Aug 16, 2024 Risk: low
  Masimo Corporation filed an 8-K on August 16, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain spec
• Masimo Corp Files 8-K on Financials — Aug 6, 2024 Risk: low
  Masimo Corporation filed an 8-K on August 6, 2024, reporting on its results of operations and financial condition. The filing also includes information related
• Masimo Corp Files 8-K on Shareholder Nominations — Jul 16, 2024 Risk: medium
  On July 15, 2024, Masimo Corporation filed an 8-K report detailing shareholder nominations for its upcoming annual meeting. The filing also includes information
• Masimo Corp Files 8-K on Financials — Jul 9, 2024 Risk: low
  Masimo Corporation filed an 8-K on July 9, 2024, to report on its results of operations and financial condition. The filing includes financial statements and ex
• Masimo Sells Non-invasive Monitoring Business for $100M — Jul 8, 2024 Risk: medium
  Masimo Corporation announced on July 2, 2024, that it has entered into a definitive agreement to sell its Non-invasive Monitoring Technologies business to an af
• Masimo Appoints New CFO, John P. Short — Jul 1, 2024 Risk: medium
  Masimo Corporation announced on June 26, 2024, the appointment of John P. Short as Chief Financial Officer, effective immediately. Mr. Short will receive an ann
• Masimo Sells Non-Core Businesses for $1.075B — Jun 7, 2024 Risk: medium
  Masimo Corporation announced on June 5, 2024, that it has entered into a definitive agreement to sell its Non-Core Businesses to an affiliate of Cerberus Capita
• Masimo Appoints New Chief Medical Officer, Legal Counsel Departs — May 8, 2024 Risk: medium
  Masimo Corporation announced on May 8, 2024, that its Board of Directors has appointed Dr. David Bruce as Chief Medical Officer, effective May 3, 2024. Dr. Bruc
• Masimo Corp Files 8-K for Financials and Reg FD — Mar 22, 2024 Risk: low
  On March 22, 2024, Masimo Corporation filed an 8-K report. The filing primarily concerns financial statements and exhibits, as well as a Regulation FD Disclosur
• Masimo Files 8-K on Financial Condition and Operations — Feb 27, 2024 Risk: medium
  MASIMO CORP ORATION filed an 8-K on February 27, 2024, disclosing information under 'Results of Operations and Financial Condition' and 'Regulation FD Disclosur
• Masimo Reports Leadership Changes and Officer Compensation — Feb 15, 2024 Risk: medium
  MASIMO CORP ORATION filed an 8-K on February 15, 2024, reporting events that occurred on February 13, 2024. The filing indicates significant changes within the
• Masimo 8-K Signals Leadership, Compensation Changes — Jan 16, 2024
  Masimo Corp. filed an 8-K on January 16, 2024, reporting an event that occurred on January 15, 2024, related to changes in directors or officers and their compe
• MASIMO CORP. FILES 8-K ON FINANCIAL RESULTS & REG FD DISCLOSURE — Jan 10, 2024
  Masimo Corp. filed an 8-K on January 10, 2024, primarily to report on its results of operations and financial condition, along with Regulation FD Disclosure and

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX